Search results
Moderna Reports First Quarter 2024 Financial Results and Provides Business Updates
Morningstar· 1 week agoReports first quarter revenues of $167 million, GAAP net loss of $1.2 billion and GAAP diluted EPS of $(3.07)Prepares for launches of RSV vaccine and Spikevax® 2024-2025 formula; reaffirms 2024 ...